pharmaceuticals

An NPR investigation found stalled confirmatory trials and lax enforcement are plaguing the FDA's accelerated approval of drugs for urgent medical needs.

Families affected by ultra-rare diseases are starting their own companies to speed the development of treatments for their kids, venturing into territory that traditional drugmakers deem too risky.

Approved as a device, not a drug, Plenity contains a plant-based gel that swells to fill 25% of a person’s stomach, to help people eat less. Results vary widely but are modest on average.

After a Tennessee nurse killed a patient because of a drug error, the companies behind hospital medication cabinets said they would make the devices safer. But did they?

In the shadow of Texas’ austere abortion regulations, grassroots organizers employ stealth tactics to help young women get emergency contraception.

Perspective: Amid skyrocketing drug prices, it’s understandable that patients desperately need help affording medicine, especially when their health is on the line. But these programs create a mirage that perpetuates our health care system’s reckless spending.

A diabetes diagnosis is not always related to a person’s weight or overall health, especially for those with Type 1 diabetes, who are dependent on insulin treatment for life.

The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for COVID. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients.

Kentucky nurse Jacqueline Brewster is accused of tampering with opioids in Tennessee and West Virginia, possibly contaminating drugs given to hospital patients.

The Trump’ administration approved a rule in 2020 to help clear the way, but groups including the Pharmaceutical Research & Manufacturers of America launched a legal challenge that remains unresolved.